SPINEMarketGroup

In recent weeks, much of the spine market discussion has focused on Globus Medical and the negative market reaction that followed otherwise strong operating results. But Globus is not alone. Medtronic, one of its most direct competitors in spine technology, has also been under pressure. Its stock recently hit a reported 52-week low at $77.15, and … [Read More...] about Medtronic Hits a 52-Week Low: What Is the Market Seeing?

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, announces the … [Read More...] about SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon

There are reimbursement disputes that affect only the margins of a market. Others say something more structural about the direction of the industry. The recent statement from leading U.S. spine surgery societies on cervical fusion implant denials belongs to the second category. The issue is not a new device seeking early coverage, nor an experimental technology asking for broader acceptance. … [Read More...] about Cervical Fusion Implant Denials: Why Spine Societies Are Pushing Back

CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U.S. patent related to Aurora’s proprietary DEXA Technology® platform. The newly issued patent, U.S. Patent No. 12,605,252 B2, titled … [Read More...] about Aurora Spine Announces Issuance of Fourth U.S. Patent Covering DEXA Technology® Bone Density-Matched Implants

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year Full year 2026 revenue guidance raised to $72 million to $77 million CARLSBAD, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the … [Read More...] about Carlsmed® Reports First Quarter 2026 Financial

CARLSBAD, Calif--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2026, and business highlights. First Quarter 2026 Financial Results First Quarter Highlights “ATEC’s surgical … [Read More...] about ATEC Reports First Quarter Financial Results

DALLAS & LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptive Implants in Orthopaedics – Euronext Growth Paris, ISIN Code: FR0014005I80 / Ticker: ALSMA), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and related services, … [Read More...] about SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2026, reflecting steady execution following recent spine commercial channel actions. Based on first-quarter performance, the Company reaffirmed its full-year 2026 financial guidance. All pro forma measures … [Read More...] about Orthofix Reports First Quarter 2026 Results Highlighting Steady Execution Following Spine Commercial Channel Actions; Reaffirms Full-Year 2026 Financial Guidance

A new study published in Global Spine Journal, carried out by researchers from Johns Hopkins together with collaborators from the All India Institute of Medical Sciences (AIIMS) in New Delhi, has put an unusual detail on the radar of spine surgeons: the long-term use of inhaled corticosteroids in asthma patients. At first sight, this may sound like a minor point. Inhaled steroids are common, … [Read More...] about Inhaled Corticosteroids and Lumbar Fusion: A New Revision Risk Signal?